CoreAge Rx advertises sermorelin from $99 per month. Eden’s injection page displays medication from $126 for the first month and requires a separate membership. The useful comparison is the complete care arrangement and charge, not just the two medication headlines.
CoreAge Rx receives featured commercial placement on this site. This comparison uses public information checked on September 20, 2026; we did not purchase treatment or test either service. It identifies practical differences without claiming that one provider’s preparation is clinically superior.
Eden separates medication and membership. Add the applicable charges and confirm renewal pricing before comparing with a selected CoreAge Rx plan.
Eden’s first-month arithmetic has two parts
The reviewed Eden page lists $126 for the first medication month and a required membership of $39 for the first month, renewing at $99 per month afterward. Adding the two displayed introductory figures gives $165. That is arithmetic from the public page, not a completed checkout quote.
The medication's later price must still be confirmed. Do not assume the introductory medication amount continues or that the membership includes medication. CoreAge Rx's $99 starting figure likewise needs the selected term, quantity, and any additional clinical charges verified before calling either offer the complete price.
Ask what you receive from membership
A required membership is part of the purchasing decision even when the medication appears on a separate card. Ask Eden which assessment, follow-up, and support services it covers, and what happens if no prescription is issued. Ask CoreAge Rx which comparable services are included in the proposed order.
The useful distinction is what happens after the initial assessment. Is a review scheduled? Can the clinician discuss an unexpected result? Is additional testing separately charged? A membership can organize services, but the existence of a fee does not by itself establish better clinical care.
A formulation choice is a separate decision
Eden also publishes an ODT, or orally disintegrating tablet, product page. That should be evaluated as a different formulation rather than a needle-free version assumed to have identical effects. Compare the route the clinician actually proposes for you with the CoreAge Rx injection information.
Ask for the pharmacy, active ingredients, directions, and evidence relevant to that preparation. Our route comparison helps distinguish convenience from demonstrated absorption or clinical benefit. A shared ingredient name does not make two prescriptions interchangeable.
Keep account eligibility separate from reimbursement
An HSA or FSA label on a website does not settle whether every charge in a membership and medication bundle qualifies for your circumstances. Request an itemized receipt and consult the applicable administrator before assuming reimbursement.
The insurance and HSA/FSA guide explains the distinction. For the service decision, read the Eden review and CoreAge Rx review, then compare the total you could owe without reimbursement. Confirm how cancellation affects both recurring components if the clinical plan changes.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- Eden: Sermorelin injectionProvider primary source · Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
- CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- Eden: Sermorelin ODTProvider primary source · Checked September 20, 2026. Advertised offering only; checkout, patient suitability, and dispensing were not tested.
- Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagoguesClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- IRS: Publication 502, Medical and Dental ExpensesUS tax authority · Medical-expense definitions; not an individual insurance or account-eligibility determination.
- IRS: Publication 969, Health Savings Accounts and Other Tax-Favored Health PlansUS tax authority · HSA/FSA qualified-expense and recordkeeping rules. Current accessible edition is for 2025; no 2026 numerical limits are inferred.